European shares hit record high on Airbus boost, Bayer hurt by Roundup ruling

* Mining stocks, banks were best performers

* Airbus jumps on hiking jet output targets

* Food and beverage stocks hurt by Tate & Lyle

By Ambar Warrick and Shreyashi Sanyal

May 27 (Reuters) - European shares closed at a record high on Thursday boosted by Airbus after the planemaker hiked its jet output targets, while German shares weakened after shares in pharmaceuticals maker Bayer were hit by a court ruling.

The pan-European STOXX 600 index .STOXX rose 0.3% to 446.44 points, a record closing high.

French planemaker Airbus AIR.PA jumped 9.2% after it set out sweeping goals to expand production of jetliners, as the airline industry recovers from the COVID-19 pandemic.

German shares .GDAXI shed around 0.3%, lagging other regional markets, with Bayer BAYGn.DE the biggest drag on the DAX, falling 5.0%.

The stock marked its worst day in three months after a U.S. judge rejected its class action plan to settle future claims related to its Roundup and other glyphosate-based weedkillers.

European shares have moved little this week, but achieved record highs as continued affirmations of easy monetary policy and waning concerns over inflation painted a favourable picture.

However, investors have been moving into more cyclical parts of equity markets for protection from the risks of rising inflation.

The European banks sector .SX7P nearly 2% and basic resources .SXPP jumped 3.0%, leading sectoral gains on Thursday.

A rise in metal prices on concerns over supply disruptions in top copper producer Chile, also helped mining stocks outperform.

"We continue to expect a rapid recovery which has also been reflected in the robust performance of European and German companies in the first quarter earnings season," said Mark Haefele, chief investment officer of global wealth management at UBS in a client note.

"We recommend that investors continue to position for the reflation trade and favour reasonably valued cyclicals that benefit from rising inflation and higher bond yields."

Food and beverage stocks .SX3P were among the worst performers, falling 0.7% on losses in British processed foods maker Tate & Lyle TATE.L . The stock shed more than 6% after its annual revenue fell.

Among other movers, Deutsche Bank DBKGn.DE rose 1% after Chief Executive Christian Sewing told shareholders that the bank's multi-year overhaul is ahead of plan and remains its primary focus, promising an era of more sustainable profit.

Puma PUMG.DE fell 0.6% after French luxury goods group Kering PRTP.PA said it will sell a 5.9% stake in the German sportswear firm through a share placement.
Reporting by Ambar Warrick and Shreyashi Sanyal in Bengaluru; Editing by Arun Koyyur, Alexander Smith and Toby Chopra

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.